Stay updated on Alvocidib Biomarker AML Phase 2 Clinical Trial

Sign up to get notified when there's something new on the Alvocidib Biomarker AML Phase 2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Alvocidib Biomarker AML Phase 2 Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page revision was updated to v3.6.6, indicating a new version of the page's metadata. No substantive content changes are introduced.
    Difference
    0.0%
    Check dated 2026-08-29T19:16:32.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5. This indicates a minor editorial or metadata update to the entry.
    Difference
    0.0%
    Check dated 2026-08-08T22:41:00.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.3 to v3.6.4 to indicate the latest page version.
    Difference
    0.0%
    Check dated 2026-07-25T12:37:05.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3, updating the site’s revision label from v3.6.2 to reflect a newer version.
    Difference
    0.0%
    Check dated 2026-07-04T00:00:13.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The page shows a new revision tag (v3.6.2) replacing the previous v3.6.0, signaling an underlying software update behind the page; no study details or displayed content appear to be affected.
    Difference
    0.0%
    Check dated 2026-06-27T00:07:42.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    The page now shows that the study is no longer looking for participants, signaling that enrollment has ceased. It also includes new help/navigation items and a formatting change to the Intervention/Treatment header as part of a UI/text refresh.
    Difference
    0.4%
    Check dated 2026-06-12T16:41:10.000Z thumbnail image

Stay in the know with updates to Alvocidib Biomarker AML Phase 2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Alvocidib Biomarker AML Phase 2 Clinical Trial page.